BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11960282)

  • 21. [CNHK200-hA-a gene-viral therapeutic system and its antitumor effect on lung cancer].
    Wang WG; Xue HB; Su CQ; Cui ZF; Nie MM; Sham J; Wu MC; Qian QJ
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):69-72. PubMed ID: 15946541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.
    Cho WK; Seong YR; Lee YH; Kim MJ; Hwang KS; Yoo J; Choi S; Jung CR; Im DS
    Mol Ther; 2004 Nov; 10(5):938-49. PubMed ID: 15509511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.
    Terao S; Shirakawa T; Kubo S; Bishunu A; Lee SJ; Goda K; Tsukuda M; Hamada K; Tagawa M; Takenaka A; Fujisawa M; Gotoh A
    Urology; 2007 Nov; 70(5):1009-13. PubMed ID: 17919690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
    Hoffmann D; Jogler C; Wildner O
    J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
    Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
    Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
    Bonovich M; Olive M; Reed E; O'Connell B; Vinson C
    Cancer Gene Ther; 2002 Jan; 9(1):62-70. PubMed ID: 11916245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
    Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
    Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting KRAS mutation-bearing lung cancer in vivo by pulmonary surfactant-adenovirus-mediated gene transfer.
    Fukazawa T; Maeda Y; Matsuoka J; Ono T; Mominoki K; Yamatsuji T; Shigemitsu K; Morita I; Murakami I; Tanaka H; Durbin ML; Naomoto Y
    Anticancer Res; 2010 Dec; 30(12):4925-35. PubMed ID: 21187472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E1A specifically enhances sensitivity to topoisomerase IIalpha targeting anticancer drug by up-regulating the promoter activity.
    Zhou Z; Guan H; Kleinerman ES
    Mol Cancer Res; 2005 May; 3(5):271-5. PubMed ID: 15886298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of adenoviral E1A-involved apoptosis of rat alveolar epithelial cells and human lung adenocarcinoma epithelial cell line].
    Chen J; Zhang J; Zheng XW; Guo YY; Fu X; Li B; Ran PX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):423-6. PubMed ID: 20423646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
    Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
    Brader KR; Wolf JK; Hung MC; Yu D; Crispens MA; van Golen KL; Price JE
    Clin Cancer Res; 1997 Nov; 3(11):2017-24. PubMed ID: 9815592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.
    Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R
    Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of adenoviral vector on expression of angiogenesis regulating factors in non-small cell lung cancer cell lines.
    Kuhn H; Riedel A; Eichler W; Aust G; Gessner C; Wirtz H
    Cancer Immunol Immunother; 2002 Oct; 51(8):461-6. PubMed ID: 12202907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
    Kim J; Cho JY; Kim JH; Jung KC; Yun CO
    Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression.
    Pipiya T; Sauthoff H; Huang YQ; Chang B; Cheng J; Heitner S; Chen S; Rom WN; Hay JG
    Gene Ther; 2005 Jun; 12(11):911-7. PubMed ID: 15690061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.